These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7998585)

  • 1. Pharmacokinetics of rilmenidine in patients with chronic renal insufficiency and in hemodialysis patients.
    Aparicio M; Dratwa M; el Esper N; Fillastre JP; Levaltier B; Lins R; Meyrier A; Mignon F; Ryckelynck JP; Sennesael J
    Am J Cardiol; 1994 Dec; 74(13):43A-50A. PubMed ID: 7998585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of rilmenidine.
    Singlas E; Ehrhardt JD; Zech P; Pozet N; Genissel P
    Am J Cardiol; 1988 Feb; 61(7):54D-59D. PubMed ID: 2894159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceptability of rilmenidine and long-term surveillance of plasma concentrations in hypertensive patients with renal insufficiency.
    Lins RL; Daelemans R; Dratwa M; Verbeelen D; Sennesael J; Brisgand B; Lameire N
    Am J Med; 1989 Sep; 87(3C):41S-45S. PubMed ID: 2782326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of rilmenidine.
    Genissel P; Bromet N
    Am J Med; 1989 Sep; 87(3C):18S-23S. PubMed ID: 2782323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of cefepime in subjects with renal insufficiency.
    Barbhaiya RH; Knupp CA; Forgue ST; Matzke GR; Guay DR; Pittman KA
    Clin Pharmacol Ther; 1990 Sep; 48(3):268-76. PubMed ID: 2401125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacokinetics of perindopril and its effects on serum angiotensin converting enzyme activity in hypertensive patients with chronic renal failure.
    Sennesael J; Ali A; Sweny P; Vandenburg M; Slovic D; Dratwa M; Resplandy G; Genissel P; Desche P
    Br J Clin Pharmacol; 1992 Jan; 33(1):93-9. PubMed ID: 1311597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of rilmenidine in healthy subjects.
    Genissel P; Bromet N; Fourtillan JB; Mignot A; Albin H
    Am J Cardiol; 1988 Feb; 61(7):47D-53D. PubMed ID: 2894158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition of didanosine in HIV-seropositive patients with normal renal function or chronic renal failure: influence of hemodialysis and continuous ambulatory peritoneal dialysis.
    Knupp CA; Hak LJ; Coakley DF; Falk RJ; Wagner BE; Raasch RH; van der Horst CM; Kaul S; Barbhaiya RH; Dukes GE
    Clin Pharmacol Ther; 1996 Nov; 60(5):535-42. PubMed ID: 8941026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of cefprozil in healthy subjects and patients with renal impairment.
    Shyu WC; Pittman KA; Wilber RB; Matzke GR; Barbhaiya RH
    J Clin Pharmacol; 1991 Apr; 31(4):362-71. PubMed ID: 2037710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of ornidazole in patients with renal insufficiency; influence of haemodialysis and peritoneal dialysis.
    Merdjan H; Baumelou A; Diquet B; Chick O; Singlas E
    Br J Clin Pharmacol; 1985 Feb; 19(2):211-7. PubMed ID: 3986079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of oral talinolol following a single dose and during steady state in patients with chronic renal failure and healthy volunteers.
    Krueger M; Achenbach H; Terhaag B; Haase H; Richter K; Oertel R; Preiss R
    Int J Clin Pharmacol Ther; 2001 Feb; 39(2):61-6. PubMed ID: 11270803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
    De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
    Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacokinetics of irbesartan in renal failure and maintenance hemodialysis.
    Sica DA; Marino MR; Hammett JL; Ferreira I; Gehr TW; Ford NF
    Clin Pharmacol Ther; 1997 Dec; 62(6):610-8. PubMed ID: 9433389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of fluconazole in renal failure.
    Berl T; Wilner KD; Gardner M; Hansen RA; Farmer B; Baris BA; Henrich WL
    J Am Soc Nephrol; 1995 Aug; 6(2):242-7. PubMed ID: 7579091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of cefoperazone (2.0 g) and sulbactam (1.0 g) coadministered to subjects with normal renal function, patients with decreased renal function, and patients with end-stage renal disease on hemodialysis.
    Reitberg DP; Marble DA; Schultz RW; Whall TJ; Schentag JJ
    Antimicrob Agents Chemother; 1988 Apr; 32(4):503-9. PubMed ID: 3377461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of anakinra in subjects with different levels of renal function.
    Yang BB; Baughman S; Sullivan JT
    Clin Pharmacol Ther; 2003 Jul; 74(1):85-94. PubMed ID: 12844139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-Dose Pharmacokinetics and Safety of Meropenem-Vaborbactam in Subjects with Chronic Renal Impairment.
    Rubino CM; Bhavnani SM; Loutit JS; Lohse B; Dudley MN; Griffith DC
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29311069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of cicletanine in patients with impaired renal function.
    Jungers P
    Drugs Exp Clin Res; 1988; 14(2-3):189-94. PubMed ID: 3416723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of renal insufficiency and hemodialysis on the pharmacokinetics of rofecoxib.
    Gottesdiener K; Agrawal N; Porras A; Wong P; Rogers JD; Gertz BJ; Redfern JS; Marbury T
    Am J Ther; 2003; 10(4):252-8. PubMed ID: 12845388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of intravenous pentamidine in patients with normal renal function or receiving hemodialysis.
    Conte JE
    J Infect Dis; 1991 Jan; 163(1):169-75. PubMed ID: 1984463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.